Home › Biotech with unproven Alzheimer's drug now worth billions
 

Keywords :   


Biotech with unproven Alzheimer's drug now worth billions

2015-06-12 08:42:22| Biotech - Topix.net

Investors are giving Axovant Sciences Ltd. an almost $3 billion valuation after its public-market debut.

Tags: worth drug biotech billions

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11STEINBACH40
24.11 Sepua Crue F-170
24.11 SECRET
24.11CRAwith
24.1111/15)&&
24.11 8
24.11
24.11F2023 23
More »